4//SEC Filing
Akinsanya Karen 4
Accession 0001490978-25-000036
CIK 0001490978other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 4:31 PM ET
Size
16.0 KB
Accession
0001490978-25-000036
Insider Transaction Report
Form 4
Akinsanya Karen
President of R&D, Therapeutics
Transactions
- Sale
Common Stock
2025-04-14$25.11/sh−8,378$210,391→ 23,970 total - Exercise/Conversion
Common Stock
2025-04-14$3.22/sh+13,378$43,077→ 29,003 total - Sale
Common Stock
2025-04-14$25.11/sh−5,000$125,555→ 18,970 total - Exercise/Conversion
Stock Option (right to buy)
2025-04-14−3,345→ 0 totalExercise: $2.92Exp: 2027-10-10→ Common Stock (3,345 underlying) - Exercise/Conversion
Common Stock
2025-04-14$2.92/sh+3,345$9,767→ 32,348 total - Exercise/Conversion
Stock Option (right to buy)
2025-04-14−13,378→ 0 totalExercise: $3.22Exp: 2028-08-03→ Common Stock (13,378 underlying) - Sale
Common Stock
2025-04-14$25.00/sh−3,345$83,625→ 15,625 total
Footnotes (6)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2024.
- [F2]Includes 15,625 unvested RSUs.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (4) of this form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (4) of this form 4.
- [F5]The option was granted on August 3, 2018 and is fully vested.
- [F6]The option was granted on October 10, 2017 and is fully vested.
Documents
Issuer
Schrodinger, Inc.
CIK 0001490978
Entity typeother
Related Parties
1- filerCIK 0001797672
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 4:31 PM ET
- Size
- 16.0 KB